1 / 6

51 Countries Discussed in Afoxolaner Patent Research Report

Complete Report @ http://goo.gl/5z7u71 "Afoxolaner – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)" report provides an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 9 countries (50 country coverage also available), regulatory issues and key players.

chrisbotham
Download Presentation

51 Countries Discussed in Afoxolaner Patent Research Report

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Afoxolaner – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries)ByArk Patent Intelligence Browse more reports on Life Sciences @ http://www.rnrmarketresearch.com/reports/life-sciences . Single User License: US $1400 Published: April 2015 © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  2. Afoxolaner – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that’s simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ! NOW WITH USA VIEW’! “The most extensive source of patent information available.” Product Portfolio Manager – DrReddysLaboratories “The database is reliable, frequently updated, well-arranged, user friendly.” Director IP – Zentivak.s “Allows me to perform an analysis on an INN in hours rather than days”. IP Council, top 10 generics company Complete report available @ http://www.rnrmarketresearch.com/afoxolaner-patent-extension-and-data-exclusivity-expiry-snapshot-50-countries-market-report.html. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  3. Afoxolaner – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) Watertight, user-friendly data you can rely on # Key patent, extension and data exclusivity expiry in one simple view # highly accurate, manually verified data # Full consideration of pediatric, orphan and complex data exclusivity # covers over 50 countries and 1600 molecules, including over 300 biologics Insight and understanding for all levels of expertise # Patents interpreted and assigned to categories # Expert constraint analysis, commentary, and SPC validity flags # Flags indicate constraining, difficult or nuisance patents # Available on a per molecule basis Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=268292. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441 © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  4. Afoxolaner – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) Save vast amounts of time # Complete, reliable and verifiable data so you don’t have to fill holes and double check # Intelligent, friendly design means fewer clicks and quicker understanding # Hyperlinking to vital patent documentation allows fast analysis and verification # Add your own notes, save searches and results This report covers: International Nonproprietary Name: Afoxolaner Indications: Treatment of tick or flea infestation in dogs Innovator: Merial (NexGard) Inquire for discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=268292. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441 © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  5. Afoxolaner – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) Country Coverage: Albania, Australia, Austria, Belgium, Bosnia & Herzegovina, Brazil, Bulgaria, Canada, China, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Mexico, Monaco, Montenegro, New Zealand, Norway, Poland, Portugal, Romania, Russia, San Marino, Serbia, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, The Netherlands, Turkey, USA. Table of Contents Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries) helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 9 countries (50 country coverage also available), regulatory issues and key players. Inquire before buying this report @ http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=268292. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441 © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

  6. Afoxolaner – Patent, Extension and Data Exclusivity Expiry Snapshot (51 countries) For more details contact Mr. RiteshTiwari:sales@rnrmarketresearch.com/ +18883915441 RnR Market Research RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnR  Market Research library has syndicated reports by leading market research  publishers across the globe. © RnRMarketResearch.com ; sales@rnrmarketresearch.com ; +1 888 391 5441

More Related